Table 1.
Characteristic | n | % |
---|---|---|
Age (y), median (range) | 77 (49–95) | |
KPS, median (range) | 70 (50–100) | |
Gender | ||
Male | 138 | 46.8 |
Female | 157 | 53.2 |
BMI (kg/m2)* | ||
<30 | 225 | 71.2 |
≥30 (obesity) | 91 | 28.8 |
Tumor | ||
Primary NSCLC | 285 | 90.2 |
Oligometastatic | 13 | 4.1 |
Recurrent | 18 | 5.7 |
Tumor distance to CW (cm) | ||
<1 | 218 | 69.0 |
≥1 | 98 | 31.0 |
Prescription doses | ||
18–20 Gy × 3 | 113 | 35.8 |
12 Gy × 4 | 114 | 36.1 |
9–10 Gy × 5 | 62 | 19.6 |
Other | 27 | 8.5 |
Abbreviations: BMI = body mass index; CW = chest wall; KPS = Karnofsky performance status; NSCLC = non-small cell lung cancer.
Body mass index for patients with multiple treatments was calculated separately before each treatment.